| | Johnson & Johnson (J&J) said it would work with the Indian government to compensate patients who had suffered from hip implants that were recalled by the U.S. healthcare firm eight years ago after data showed high failure rates. | | | The African swine fever spreading rapidly in China is "here to stay", the U.N. Food and Agriculture Organization said on Friday, adding that it was almost certain to spread to other Asian countries. | | | Canada's TELUS Health is joining forces with London-based AI company Babylon to bring virtual medical services, including video consultations, to Canadians who do not have a family doctor or are in rural locations far from a surgery. | | | (Reuters Health) - People who have recently experienced a stroke may be more than twice as likely to develop dementia than individuals who haven't had a stroke, a new study suggests. | | | Akcea Therapeutics Inc said on Thursday it planned to cut its workforce by about 10 percent after the U.S. health regulator declined to approve its Waylivra drug for treating a genetic disease that causes fat accumulation in blood. | | | (Reuters Health) - Most U.S. four-year colleges and universities as well as community colleges don't have tobacco-free or smoke-free policies on campus, a new study finds. | | | (Reuters Health) - People who have weight-loss surgery for extreme obesity may lose more weight with an older operation known as Roux-en-Y gastric bypass than with a newer sleeve gastrectomy procedure, a small U.S. study suggests. | | | (Reuters Health) - Adolescents who worry about discrimination in society may be more likely to drink, smoke or experiment with drugs than teens who don't have these concerns, a U.S. study suggests. | | | New Novartis Chief Executive Vas Narasimhan has further reshaped the Swiss drugmaker, announcing on Thursday he is selling U.S. dermatology and generic pill assets to India's Aurobindo Pharma Ltd for up to $1 billion. | | | (Reuters Health) - Kids born through in vitro fertilization may be more likely to develop high blood pressure, a new study suggests. | | | Maryland on Thursday charged Insys Therapeutics Inc with deceptively marketing a powerful opioid pain killer so that it was prescribed inappropriately beyond its intended use with cancer patients. | | | | |